Back to Search
ROBERT SMITH, DDS
DDS
General Practice Dentistry
NPI: 1215088570Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
46218(CA)
Clinical Trials (4)
4
Linked Trials
0
Recruiting
3
With Results
Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
NCT00287820COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Varenicline Effects In Schizophrenic Smokers
NCT00548470COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
NCT00231894COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
NCT00802919COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (7)
Nicotine receptor partial agonists for smoking cessation.
PMID 37142273·Cochrane Database Syst Rev·2023
1-meta
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
PMID 26730716·PLoS One·2016
4-observational
Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study.
PMID 23200554·Schizophr Res·2013
2-rct
Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients.
PMID 22475524·Psychiatry Res·2012
2-rct
Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
PMID 20457512·Schizophr Res·2010
2-rct
Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study.
PMID 19814947·J Clin Psychiatry·2009
4-observational
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
PMID 19251401·Schizophr Res·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6191 N. FRESNO ST #102
FRESNO, CA 93710 - Phone
- (559) 438-4031
Quick Facts
- NPI
- 1215088570
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 7
Are you this provider?
Claim Your Profile